Papillary infarction is commonly observed in ovarian atypical proliferative serous and seromucinous tumors (APST/APSMT), but there are no published data on its significance. This study characterizes the features associated with papillary infarcts and microinvasion to further understand these phenomena. From consecutive hospital-based cases, 32 APST/APSMT in 26 patients (6 bilateral) were reviewed and evaluated for papillary infarcts, microinvasion (<5 mm), and other histologic features. Among the tumors, 69% were APSTs and 31% APSMTs. Infarcts were identified in 46% of patients, and microinvasion in 27%. Microinvasion was significantly more common in tumors with infarcts (50%) than in those without (7%; P=0.0261). Papillary infarcts were significantly more common in APSTs (61%) than in APSMTs (13%; P=0.0357). The microinvasive tumors were significantly more likely to be bilateral (57% vs. 11%, P=0.0278). The mean infarct size in the presence of microinvasion was 5.9 mm, and in the absence of microinvasion, 2.2 mm (not significant). The infarcts were topographically separate from the foci of microinvasion. Other features evaluated showed no meaningful correlations with microinvasion or infarction. Proliferative noninvasive serous tumors with papillary infarcts are significantly more likely to have microinvasion, and papillary infarcts are more common in APSTs than in APSMTs. APSTs with microinvasion are more common than earlier appreciated. Whether papillary infarction is pathogenetically related to microinvasion is unknown and warrants further investigation.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/PGP.0b013e3181cc824f | DOI Listing |
Eur Heart J Case Rep
October 2024
Centro Cardiologico Monzino IRCCS, Milan, Italy.
Background: Acute mitral regurgitation due to papillary muscle rupture is a severe complication of acute myocardial infarction. Transcatheter edge-to-edge repair is emerging as an effective alternative to surgical treatment, with encouraging outcomes. Leaflet adverse events are rare and are associated with relapse of significant mitral regurgitation.
View Article and Find Full Text PDFInt J Surg Case Rep
November 2024
Department of Cardiovascular Surgery, Kumamoto University Hospital, Kumamoto, Japan.
Introduction: Mitral regurgitation is a potential complication of transcatheter aortic valve replacement. Here, we report a case of severe acute mitral regurgitation caused by papillary muscle rupture occurring 16 days after transcatheter aortic valve replacement.
Presentation Of Case: An 82-year-old woman with severe AS was referred to our hospital.
Cureus
October 2024
Cardiovascular Medicine/Cardiology, College of Medicine, Kasr Alainy University, Cairo, EGY.
J Investig Med High Impact Case Rep
November 2024
Eisenhower Health, Rancho Mirage, CA, USA.
Papillary muscle rupture is commonly linked to ischemic events, occurring typically postmyocardial infarction. However, iatrogenic and nonischemic etiologies can play a role in papillary muscle rupture, including infective endocarditis. The case presented herein is an 85-year-old female with a history of heart failure with preserved ejection fraction (HFpEF), who presented with progressive dyspnea despite furosemide therapy, and was discovered to have a flail posterior mitral valve leaflet secondary to papillary muscle rupture associated with endocarditis.
View Article and Find Full Text PDFJ Clin Ultrasound
November 2024
Department of Pathology, Güven Hospital, Ankara, Turkey.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!